Widespread intra-serotype recombination in natural populations of dengue virus.

PubWeight™: 2.12‹?› | Rank: Top 2%

🔗 View Article (PMC 22089)

Published in Proc Natl Acad Sci U S A on June 22, 1999

Authors

M Worobey1, A Rambaut, E C Holmes

Author Affiliations

1: Department of Zoology, University of Oxford, South Parks Road, Oxford, OX1 3PS, United Kingdom. michael.worobey@zoo.ox.ac.uk

Articles citing this

A coalescent-based method for detecting and estimating recombination from gene sequences. Genetics (2002) 7.41

Microevolution and virulence of dengue viruses. Adv Virus Res (2003) 3.41

Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India. Virol J (2008) 1.99

Myanmar dengue outbreak associated with displacement of serotypes 2, 3, and 4 by dengue 1. Emerg Infect Dis (2004) 1.68

Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys. J Virol (2005) 1.56

Natural attenuation of dengue virus type-2 after a series of island outbreaks: a retrospective phylogenetic study of events in the South Pacific three decades ago. Virology (2010) 1.53

Dengue--quo tu et quo vadis? Viruses (2011) 1.50

A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeys. J Virol (2003) 1.50

Evidence of recombination in the norovirus capsid gene. J Virol (2005) 1.41

Genome-wide screen identifies host genes affecting viral RNA recombination. Proc Natl Acad Sci U S A (2005) 1.34

Use of a short fragment of the C-terminal E gene for detection and characterization of two new lineages of dengue virus 1 in India. J Clin Microbiol (2006) 1.32

Molecular epidemiology of dengue viruses in southern China from 1978 to 2006. Virol J (2011) 1.29

Diverse dengue type 2 virus populations contain recombinant and both parental viruses in a single mosquito host. J Virol (2003) 1.29

Screening of the yeast yTHC collection identifies essential host factors affecting tombusvirus RNA recombination. J Virol (2006) 1.23

Topology of viral evolution. Proc Natl Acad Sci U S A (2013) 1.19

Models of dengue virus infection. Drug Discov Today Dis Models (2006) 1.18

Multiple recombinant dengue type 1 viruses in an isolate from a dengue patient. J Gen Virol (2007) 1.16

Evidence of recombination in intrapatient populations of hepatitis C virus. PLoS One (2008) 1.16

Genetic diversity of the E protein of dengue type 3 virus. Virol J (2009) 1.15

Dengue virus virulence and transmission determinants. Curr Top Microbiol Immunol (2010) 1.15

High-resolution analysis of intrahost genetic diversity in dengue virus serotype 1 infection identifies mixed infections. J Virol (2011) 1.14

Molecular evolution of Puumala hantavirus. J Virol (2001) 1.13

Transfection-mediated generation of functionally competent Tula hantavirus with recombinant S RNA segment. EMBO J (2002) 1.09

Suppression of viral RNA recombination by a host exoribonuclease. J Virol (2006) 1.09

Size heterogeneity in the 3' noncoding region of South American isolates of yellow fever virus. J Virol (2005) 1.06

A trans-complementing recombination trap demonstrates a low propensity of flaviviruses for intermolecular recombination. J Virol (2010) 1.05

Simultaneous circulation of genotypes I and III of dengue virus 3 in Colombia. Virol J (2008) 1.02

Recombination in West Nile Virus: minimal contribution to genomic diversity. Virol J (2009) 0.98

Hybridization in Parasites: Consequences for Adaptive Evolution, Pathogenesis, and Public Health in a Changing World. PLoS Pathog (2015) 0.93

Extensive homologous recombination among widely divergent TT viruses. J Virol (2000) 0.91

Feasibility of using 454 pyrosequencing for studying quasispecies of the whole dengue viral genome. BMC Genomics (2012) 0.89

Nucleotide-resolution profiling of RNA recombination in the encapsidated genome of a eukaryotic RNA virus by next-generation sequencing. J Mol Biol (2012) 0.89

Simple Prognostic Criteria can Definitively Identify Patients who Develop Severe Versus Non-Severe Dengue Disease, or Have Other Febrile Illnesses. J Clin Med Res (2012) 0.89

The NS1 glycoprotein can generate dramatic antibody-enhanced dengue viral replication in normal out-bred mice resulting in lethal multi-organ disease. PLoS One (2011) 0.86

Prolonged co-circulation of two distinct Dengue virus Type 3 lineages in the hyperendemic area of Medellin, Colombia. Am J Trop Med Hyg (2010) 0.86

Distribution of fitness in populations of dengue viruses. PLoS One (2014) 0.83

Specific genetic markers for detecting subtypes of dengue virus serotype-2 in isolates from the states of Oaxaca and Veracruz, Mexico. BMC Microbiol (2008) 0.83

Multiple recombinants in two dengue virus, serotype-2 isolates from patients from Oaxaca, Mexico. BMC Microbiol (2009) 0.83

The haemagglutinin gene, but not the neuraminidase gene, of 'Spanish flu' was a recombinant. Philos Trans R Soc Lond B Biol Sci (2001) 0.83

Recombination and positive selection identified in complete genome sequences of Japanese encephalitis virus. Arch Virol (2011) 0.81

HIV classification using the coalescent theory. Bioinformatics (2010) 0.81

Large-scale sequencing and the natural history of model human RNA viruses. Future Virol (2012) 0.79

Phylogenetic and molecular characterization of chicken anemia virus in southern China from 2011 to 2012. Sci Rep (2013) 0.79

Evidence for a complex mosaic genome pattern in a full-length hepatitis C virus sequence. Evol Bioinform Online (2008) 0.79

Stability of yellow fever virus under recombinatory pressure as compared with chikungunya virus. PLoS One (2011) 0.79

Genetic shifting: a novel approach for controlling vector-borne diseases. Trends Parasitol (2014) 0.78

A model-based information sharing protocol for profile Hidden Markov Models used for HIV-1 recombination detection. BMC Bioinformatics (2014) 0.77

Nature and Extent of Genetic Diversity of Dengue Viruses Determined by 454 Pyrosequencing. PLoS One (2015) 0.76

Evolution and evolvability of proteins in the laboratory. Proc Natl Acad Sci U S A (2004) 0.75

Impact of dengue virus (DENV) co-infection on clinical manifestations, disease severity and laboratory parameters. BMC Infect Dis (2016) 0.75

Competitive advantage of a dengue 4 virus when co-infecting the mosquito Aedes aegypti with a dengue 1 virus. BMC Infect Dis (2016) 0.75

The Molecular Epidemiology and Evolution of Murray Valley Encephalitis Virus: Recent Emergence of Distinct Sub-lineages of the Dominant Genotype 1. PLoS Negl Trop Dis (2015) 0.75

Articles cited by this

Dengue and dengue hemorrhagic fever. Clin Microbiol Rev (1998) 19.59

Pathogenesis of dengue: challenges to molecular biology. Science (1988) 14.73

Analyzing the mosaic structure of genes. J Mol Evol (1992) 10.99

Dengue: the risk to developed and developing countries. Proc Natl Acad Sci U S A (1994) 7.76

Recombination in HIV-1. Nature (1995) 5.72

Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology (1990) 4.65

Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol (1994) 4.47

A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol (1998) 3.65

Role of interspecies transfer of chromosomal genes in the evolution of penicillin resistance in pathogenic and commensal Neisseria species. J Mol Evol (1992) 3.44

Molecular evolution and phylogeny of dengue-4 viruses. J Gen Virol (1997) 3.30

Phylogenetic evidence for recombination in dengue virus. Mol Biol Evol (1999) 3.28

Dengue 3 virus transmission in Africa. Am J Trop Med Hyg (1986) 2.17

Phylogenetic relationships of dengue-2 viruses. Virology (1993) 2.16

A case of natural concurrent human infection with two dengue viruses. Am J Trop Med Hyg (1985) 2.04

Differences between cell membrane fusion activities of two dengue type-1 isolates reflect modifications of viral structure. Virology (1993) 1.86

Molecular evolution of dengue type 2 virus in Thailand. Am J Trop Med Hyg (1998) 1.63

High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J Virol (1994) 1.52

Genetic relatedness among structural protein genes of dengue 1 virus strains. J Gen Virol (1989) 1.21

Nucleotide sequences of the nonstructural protein NS1 gene of three dengue-2 viruses, M1, M2 and M3, isolated in Malaysia from patients with dengue haemorrhagic fever, dengue shock syndrome and dengue fever, respectively. Nucleic Acids Res (1990) 0.85

Nucleotide sequence of the envelope protein gene of a Malaysian dengue-2 virus isolated from a patient with dengue fever. Nucleic Acids Res (1989) 0.84

Molecular epidemiology of Malaysian dengue 2 viruses isolated over twenty-five years (1968-1993). Res Virol (1999) 0.83

Articles by these authors

Bayesian coalescent inference of past population dynamics from molecular sequences. Mol Biol Evol (2005) 18.57

Comparative analysis by independent contrasts (CAIC): an Apple Macintosh application for analysing comparative data. Comput Appl Biosci (1995) 16.80

HIV evolution: CTL escape mutation and reversion after transmission. Nat Med (2004) 10.21

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol (1993) 8.07

Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci U S A (2001) 7.90

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med (2001) 6.51

Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41

The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Mol Biol Evol (2003) 4.99

The epidemic behavior of the hepatitis C virus. Science (2001) 4.81

An integrated framework for the inference of viral population history from reconstructed genealogies. Genetics (2000) 4.23

Evolutionary aspects of recombination in RNA viruses. J Gen Virol (1999) 3.74

Population dynamics of flaviviruses revealed by molecular phylogenies. Proc Natl Acad Sci U S A (1996) 3.69

Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery (1968) 3.56

Extinction rates can be estimated from molecular phylogenies. Philos Trans R Soc Lond B Biol Sci (1994) 3.47

Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol (1992) 3.37

Phylogenetic evidence for recombination in dengue virus. Mol Biol Evol (1999) 3.28

Genetic analysis of West Nile New York 1999 encephalitis virus. Lancet (1999) 3.12

Complete mitochondrial genome sequences of two extinct moas clarify ratite evolution. Nature (2001) 3.12

Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol (1993) 2.87

Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci U S A (2006) 2.77

Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period. Virology (2002) 2.53

Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol (1994) 2.53

Ecology and evolution of rabies virus in Europe. J Gen Virol (1999) 2.52

Determinants of rate variation in mammalian DNA sequence evolution. J Mol Evol (1996) 2.49

Causes of HIV diversity. Nature (1995) 2.48

Inferring population history from molecular phylogenies. Philos Trans R Soc Lond B Biol Sci (1995) 2.21

Human immunodeficiency virus. Phylogeny and the origin of HIV-1. Nature (2001) 2.20

A likelihood method for the detection of selection and recombination using nucleotide sequences. Mol Biol Evol (1997) 2.20

Investigation of potential HIV transmission to the patients of an HIV-infected surgeon. JAMA (1993) 2.17

BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg (1974) 2.14

Networks and groups within the genus Neisseria: analysis of argF, recA, rho, and 16S rRNA sequences from human Neisseria species. Mol Biol Evol (1999) 2.10

The role of MCM proteins in the cell cycle control of genome duplication. Bioessays (1996) 2.09

The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg (1991) 2.06

Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.00

Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer (1994) 1.95

Parathyroid carcinoma: a collective review. Ann Surg (1969) 1.94

Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics (1999) 1.93

Comparative analyses for adaptive radiations. Philos Trans R Soc Lond B Biol Sci (2000) 1.91

A rational approach to the surgical management of melanoma. Ann Surg (1977) 1.88

Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res (1997) 1.84

GENIE: estimating demographic history from molecular phylogenies. Bioinformatics (2002) 1.83

A multigene analysis of the phylogenetic relationships among the flaviviruses (Family: Flaviviridae) and the evolution of vector transmission. Arch Virol (2005) 1.72

Revealing the history of infectious disease epidemics through phylogenetic trees. Philos Trans R Soc Lond B Biol Sci (1995) 1.65

Complete sequence of two tick-borne flaviviruses isolated from Siberia and the UK: analysis and significance of the 5' and 3'-UTRs. Virus Res (1997) 1.63

Molecular epidemiology of dengue virus type 3 in Venezuela. J Gen Virol (2003) 1.61

Epidemic dynamics revealed in dengue evolution. Mol Biol Evol (2009) 1.58

The molecular evolution of the alcohol dehydrogenase and alcohol dehydrogenase-related genes in the Drosophila melanogaster species subgroup. Mol Biol Evol (1994) 1.58

Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma. N Engl J Med (1976) 1.57

Phylogenetic relationships among rhabdoviruses inferred using the L polymerase gene. J Gen Virol (2005) 1.55

Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet (1995) 1.54

Genetic diversity of Borrelia burgdorferi sensu lato in ticks from mainland Portugal. J Clin Microbiol (2000) 1.50

In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J Virol (1994) 1.50

Molecular epidemiology of dengue type 2 virus in Venezuela: evidence for in situ virus evolution and recombination. J Gen Virol (2001) 1.48

Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol (1996) 1.46

A reevaluation of the higher taxonomy of viruses based on RNA polymerases. J Virol (1996) 1.44

Population dynamics of HIV-1 inferred from gene sequences. Genetics (1999) 1.43

A phylogenetic survey of recombination frequency in plant RNA viruses. Arch Virol (2005) 1.39

Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation. Immunol Lett (2001) 1.37

Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. Oncogene (1995) 1.34

Genetic analysis of Israel acute paralysis virus: distinct clusters are circulating in the United States. J Virol (2008) 1.34

Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control (1991) 1.34

Variable immune-driven natural selection in the attachment (G) glycoprotein of respiratory syncytial virus (RSV). J Mol Evol (2001) 1.32

The power of relative rates tests depends on the data. J Mol Evol (2000) 1.32

Evidence for the non-quasispecies evolution of RNA viruses [corrected]. Mol Biol Evol (2001) 1.31

Secondary structure of the 3'-untranslated region of yellow fever virus: implications for virulence, attenuation and vaccine development. J Gen Virol (1997) 1.28

PSeq-Gen: an application for the Monte Carlo simulation of protein sequence evolution along phylogenetic trees. Comput Appl Biosci (1997) 1.28

Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. J Card Surg (2000) 1.28

Immune and artificial selection in the haemagglutinin (H) glycoprotein of measles virus. J Gen Virol (2001) 1.26

Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis. J Hepatol (2001) 1.25

Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. J Gen Virol (1993) 1.24

Analysis of flavivirus envelope proteins reveals variable domains that reflect their antigenicity and may determine their pathogenesis. Virus Res (1995) 1.24

Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst (1993) 1.23

Primer Master: a new program for the design and analysis of PCR primers. Comput Appl Biosci (1996) 1.23

Pulmonary resection for metastatic sarcoma. Am J Surg (1980) 1.22

New inferences from tree shape: numbers of missing taxa and population growth rates. Syst Biol (2002) 1.22

Biological consequences of deletions within the 3'-untranslated region of flaviviruses may be due to rearrangements of RNA secondary structure. Virus Res (1999) 1.22

Evolution of the human immunodeficiency virus envelope gene is dominated by purifying selection. Genetics (2006) 1.20

Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol (1994) 1.18

Evolution, epidemiology, and dispersal of flaviviruses revealed by molecular phylogenies. Adv Virus Res (2001) 1.17

The evolutionary dynamics of canid and mongoose rabies virus in Southern Africa. Arch Virol (2007) 1.17

Sequence data as evidence. Nature (1993) 1.17

Testing the Cambrian explosion hypothesis by using a molecular dating technique. Proc Natl Acad Sci U S A (1998) 1.16

Recombination between sequences of hepatitis B virus from different genotypes. J Mol Evol (1996) 1.12

Changes in the surgical management of esophageal cancer from 1970 to 1993. Am J Surg (1995) 1.11

Complete nucleotide sequence and transcriptional analysis of snakehead fish retrovirus. J Virol (1996) 1.11

Pseudomembranous colitis associated with cephazolin therapy. Am J Surg (1977) 1.10

Detection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): phylogenetic relationships with human and other primate genotypes. J Virol (2000) 1.08

Regional lymph node metastases and the level of invasion of primary melanoma. Cancer (1976) 1.08

Evolution of base composition and codon usage bias in the genus Flavivirus. J Mol Evol (2001) 1.07

Management of acute cardiac failure with mechanical assist: experience with the ABIOMED BVS 5000. Ann Thorac Surg (2001) 1.07

Human origins and ancient human DNA. Science (2001) 1.07

Geographic and species association of hepatitis B virus genotypes in non-human primates. Virology (2003) 1.06

The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study. Surgery (1978) 1.05

Immunotherapy of malignancy in humans. Current status. JAMA (1975) 1.05

Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group. Cancer (1984) 1.04